We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-10.56%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.98B
AUM Growth
-$122M
Cap. Flow
+$122M
Cap. Flow %
6.17%
Top 10 Hldgs %
22.19%
Holding
209
New
50
Increased
69
Reduced
49
Closed
37

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$52.1M
2
WBD icon
Warner Bros
WBD
+$34M
3
VTRS icon
Viatris
VTRS
+$33.3M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$28.3M
5
AKAM icon
Akamai
AKAM
+$27.8M

Top Sells

Rank Stock Value
1
TAP icon
Molson Coors Class B
TAP
+$37.4M
2
ES icon
Eversource Energy
ES
+$34.8M
3
T icon
AT&T
T
+$30M
4
SSNC icon
SS&C Technologies
SSNC
+$28M
5
PGNY icon
Progyny
PGNY
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 22.24%
2 Consumer Discretionary 18.14%
3 Healthcare 12.54%
4 Industrials 8.78%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZ icon
76
LegalZoom.com
LZ
$973M
$9.46M 0.48%
+1,098,329
New +$9.83M
IIIN icon
77
Insteel Industries
IIIN
$626M
$9.25M 0.47%
351,653
+136,494
+63% +$3.79M
EQX icon
78
Equinox Gold
EQX
$13.5B
$9.09M 0.46%
1,320,532
+99,691
+8% +$639K
HAIN icon
79
Hain Celestial
HAIN
$53.4M
$9.02M 0.46%
2,174,523
+155,534
+8% +$695K
MNRO icon
80
Monro
MNRO
$368M
$8.84M 0.45%
610,784
+131,357
+27% +$2.51M
KSS icon
81
Kohl's
KSS
$2.16B
$8.84M 0.45%
1,080,436
+41,676
+4% +$484K
RIVN icon
82
Rivian
RIVN
$23.7B
$8.83M 0.45%
709,173
+638,485
+903% +$8.04M
MTUS icon
83
Metallus
MTUS
$900M
$8.7M 0.44%
+651,273
New +$9.47M
GOLD
84
Gold.com Inc
GOLD
$1.26B
$8.55M 0.43%
+337,075
New +$9.33M
BILL icon
85
BILL Holdings
BILL
$4.91B
$7.99M 0.4%
174,211
+151,413
+664% +$10.2M
SEE
86
DELISTED
Sealed Air
SEE
$7.92M 0.4%
273,897
+213,944
+357% +$7.01M
OXM icon
87
Oxford Industries
OXM
$556M
$7.79M 0.39%
132,747
+56,832
+75% +$4.09M
EGHT icon
88
8x8 Inc
EGHT
$324M
$7.67M 0.39%
3,835,364
-1,352,184
-26% -$3.48M
PGNY icon
89
Progyny
PGNY
$2.18B
$7.61M 0.38%
340,668
-1,281,461
-79% -$27.6M
STT icon
90
State Street
STT
$51.3B
$7.29M 0.37%
81,449
-115,936
-59% -$11.1M
ROG icon
91
Rogers Corp
ROG
$2.29B
$7.24M 0.37%
+107,251
New +$9.23M
HAE icon
92
Haemonetics
HAE
$3.94B
$6.78M 0.34%
+106,730
New +$7.26M
LASR icon
93
nLIGHT
LASR
$2.88B
$6.76M 0.34%
+870,390
New +$8.76M
ADM icon
94
Archer Daniels Midland
ADM
$38.8B
$6.71M 0.34%
+139,667
New +$6.75M
CXT icon
95
Crane NXT
CXT
$2.96B
$6.46M 0.33%
125,627
-14,261
-10% -$836K
MHK icon
96
Mohawk Industries
MHK
$9.19B
$6.4M 0.32%
+56,023
New +$6.68M
ZD icon
97
Ziff Davis
ZD
$2B
$6.35M 0.32%
169,062
+40,942
+32% +$1.96M
PENG
98
Penguin Solutions Inc
PENG
$2.83B
$6.33M 0.32%
+364,632
New +$7.17M
CMP icon
99
Compass Minerals
CMP
$1.13B
$6.31M 0.32%
679,694
-159,013
-19% -$1.82M
FARO
100
DELISTED
Faro Technologies
FARO
$6.28M 0.32%
230,114
-111,856
-33% -$3.28M

Similar funds

Invenomic Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Invenomic Capital Management held 209 positions worth $1.98B, down 5.8% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Invenomic Capital Management deployed $122M of net new capital in Q1 2025, opening 50 new positions and adding to 69 existing holdings. Its largest new stake was Warner Bros: 3,254,123 shares worth $34.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Eversource Energy, an estimated $34.8M trimmed.

  • Invenomic Capital Management's largest Q1 2025 buy was Warner Bros: 3,254,123 shares worth $34.9M.
  • Invenomic Capital Management added most to Teleflex in Q1 2025, an estimated $52.1M increase.
  • Invenomic Capital Management's biggest Q1 2025 reduction was Eversource Energy, cutting an estimated $34.8M.
  • Invenomic Capital Management fully exited Molson Coors Class B in Q1 2025, selling an estimated $37.4M.
  • Invenomic Capital Management's ten largest holdings make up 22% of its $1.98B portfolio in Q1 2025.
  • Invenomic Capital Management opened 50 new positions and closed 37 in Q1 2025.
  • Invenomic Capital Management's portfolio value fell 5.8% quarter-over-quarter to $1.98B.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.